151. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort
- Author
-
Hongxia Yang, Xiaolan Tian, Lining Zhang, Wenli Li, Qingyan Liu, Wei Jiang, Qinglin Peng, Guochun Wang, and Xin Lu
- Subjects
Muscle biopsy ,Idiopathic inflammatory myopathies ,Immune-mediated necrotising myopathy ,Pathological features ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Objective Immune-mediated necrotising myopathy (IMNM) is a subset of idiopathic inflammatory myopathies (IIM) characterized by significantly elevated creatine kinase level, muscle weakness and predominant muscle fibre necrosis in muscle biopsy. This study aimed to investigate the clinical and pathological characteristics of patients with IMNM in a single-centre muscle biopsy cohort. Methods A total of 860 patients who had muscle biopsy reports in our centre from May 2008 to December 2017 were enrolled in this study. IMNM was diagnosed according to the 2018 European Neuromuscular Centre (ENMC) clinicopathological diagnostic criteria for IMNM. Results The muscle biopsy cohort consisted of 531 patients with IIM (61.7%), 253 patients with non-IIM (29.4%), and 76 undiagnosed patients (8.8%). IIM cases were classified as IMNM (68[7.9%]), dermatomyositis (346[40.2%]), anti-synthetase syndrome (82[9.5%]), polymyositis (32[3.7%]), and sporadic inclusion body myositis (3[0.3%]). Limb girdle muscular dystrophy (LGMD) 2B and lipid storage myopathy (LSM) are the two most common non-IIM disorders in our muscle biopsy cohort. IMNM patients had a higher onset age (41.57 ± 14.45 vs 21.66 ± 7.86 and 24.56 ± 10.78, p
- Published
- 2022
- Full Text
- View/download PDF